Lipid levels and risk of venous thrombosis: results from the MEGA-study

Abstract

The relationship between lipid levels and risk of venous thrombosis is not well established. We aimed to assess the association between several lipids and risk of venous thrombosis using data from a population-based case–control study, and to evaluate the underlying mechanism, considering confounding by common risk factors and mediation via hemostatic factors and C-reactive protein. From the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis (MEGA) study, 2234 patients with a first venous thrombosis and 2873 controls were included. Percentile categories of total/low-density lipoprotein/high-density lipoprotein cholesterol, triglycerides, and apolipoproteins B and A1 were established in controls (<10th, 10th–25th, 25th–75th [reference], 75th–90th, >90th percentile). In age- and sex-adjusted models, decreasing levels of apolipoproteins B and A1 were dose-dependently associated with increased thrombosis risk, with odds ratios of 1.35 (95% confidence interval 1.12–1.62) and 1.50 (95% confidence interval 1.25–1.79) for the lowest category versus the reference category, respectively. The dose–response relation remained with further adjustment for body mass index, estrogen use, statin use, and diabetes. Although apolipoproteins B and A1 were associated with several hemostatic factors and C-reactive protein, none explained the increased risk in mediation analyses. The other lipids were not associated with venous thrombosis risk. In conclusion, decreasing levels of apolipoproteins B and A1 were associated with increased risk of venous thrombosis. Our findings are consistent with experimental data on the anticoagulant properties of apolipoproteins B and A1. These findings need to be confirmed and the underlying mechanism further investigated.Electronic supplementary materialThe online version of this article (doi:10.1007/s10654-017-0251-1) contains supplementary material, which is available to authorized users.

Cardiovascular Risk Factors Associated With Venous Thromboembolism

“…For example, apolipoprotein B and lipoprotein(a) levels were each associated with lower risk of VTE, a finding that awaits further elucidation. 41 Proinflammatory soluble biomarkers (eg, C-reactive protein) were positively associated with VTE, a finding consistent with the associations we observed for CHD outcomes. Although previous mendelian randomization studies suggest that CRP and fibrinogen levels are unlikely to be direct causal factors in CHD, 42,43 such genetic epidemiological data are sparser in relation to VTE.…”

The association of genetic variants in the cholesteryl ester transfer protein gene with hemostatic factors and a first venous thrombosis

“…On the basis of this evidence, our null associations between the genetically determined CETP concentration and both prothrombin (FII) and FX activity were unexpected. Nevertheless, our results are in line with our previous findings showing no association between lipid levels and the risk of a first VT . This is relevant, because CETP concentrations are highly inversely associated with HDL‐C levels .…”

Early diagnosis and precision treatment of right ovarian vein and inferior vena cava thrombosis following caesarean section: A case report

“…Lipids constitute a large part of the arterial wall, as do plasma and intracellular membranes. Therefore, lipid abnormalities may lead to endothelial damage and vascular injury (13). Cesarean section raises the risk of OVT compared with vaginal delivery as when veins are dilated and blood flow velocity decreases under anesthesia, tissue trauma is increased, bed rest is prolonged and the incidence of puerperal infection is higher due to surgery (14).…”